The West Africa Regional HIV Pharmaceutical Management Information Dashboard is developed and implemented for fifteen focus West African countries for better management of HIV and AIDS commodities. The goal of the Dashboard is to capture, track, aggregate, and disseminate information about antiretroviral drugs (ARVs), rapid test kits (RTKs), and other HIV and AIDS commodities to support evidence-based decision making in the West Africa subregion. The Dashboard will assist focus countries and subregional organizations in improving forecasting, supply planning, and procurement to support the continuous availability of ARVs, RTKs, and other HIV- and AIDS-related commodities.
Archive | West Africa Regional ProjectRSS feed for this section
The goal of the OSPSIDA Dashboard is to capture, track, aggregate, and disseminate information about antiretroviral drugs (ARVs), rapid test kits (RTKs), and other HIV and AIDS commodities to support evidence-based decision making in the West Africa subregion. The Dashboard offers regional partners a platform through which they may easily share information on funding flows and stock-out risks. The data available on this platform will be used to inform decision making and assist in identifying solutions to mitigate risks in the short-, medium-, and long-term. This User Guide assists users to make entries into the OSPSIDA Dashboard smoothly. The user guide has step-by-step guidance on how to access the dashboard, enter information, and generate reports.
Alerts on stock-outs of lifesaving antiretrovirals emerged in a number of countries in the West African region in 2012 and 2013. Several root causes for this have been identified, including a lack of tools to improve the sharing of HIV and AIDS commodity information among stakeholders for faster decision making. This greatly affects the ability of partners to anticipate the needs of the host country, leads to delays in providing support, and creates doubt in the mind of the donors as to actual needs.
The USAID-funded SIAPS Program, implemented by Management Sciences for Health, has provided support to six countries in West and Central Africa—Benin, Burkina Faso, Cameroon, Guinea, Niger, and Togo—to set up a web-based EWS to monitor HIV and AIDS commodities.
A strong pharmaceutical management system is critical for responding to and preventing public health emergencies. The US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, implemented by Management Sciences for Health (MSH), is helping four countries affected by Ebola—Sierra Leone, Guinea, Mali, and Benin—recover and rebuild essential drug management and delivery services and to increase their capacity and sustainability. The two-year project began in 2015.
Stakeholders Meeting on the Use of HIV and AIDS Pharmaceutical Management Information for Faster Decision Making
Alerts about stock-outs of life-saving medicines for antiretroviral therapy (ART) and treating opportunistic infections have been issued in a number of countries in West Africa (WA). Eight countries in the region have not only reported stock-outs of critical medications, but have also demonstrated a lack of capacity to identify and address the underlying causes of stock-outs or to generate accurate and reliable data for decision making.
To provide effective long-term solutions, the US Agency for International Development’s (USAID) West Africa office requested that the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program provide support to six countries in the WA region. Based on information collected from the rapid situational analyses in five countries, SIAPS developed a regional dashboard to serves as an early warning indicators system (EWS) for monitoring HIV and AIDS commodities to detect and minimize the risk of stock-outs in six focus countries.
On April 20-21, 2015, SIAPS and WAHO co-facilitated a regional stakeholders meeting for representatives of National AIDS Control Programs (NACP), managers of Central Medical Stores, and pharmaceutical commodity managers from the WA region, as well as representatives from other organizations operating in the region
About one-third to one-half of all antibiotics used in hospitals is for surgical prophylaxis; however, 30 to 90 percent of this use is inappropriate. The Jordan Food and Drug Administration (JFDA) recently conducted a study in Jordanian hospitals that provided data on surgical antibiotic prophylaxis practices, including for cesarean section. The study findings indicated that these practices could be improved. In the context of the JFDA’s study findings and recommendations, the U.S. Agency for International Development-funded Strengthening Pharmaceutical Systems (SPS) program, and its follow-on Systems for Improved Access to Pharmaceuticals and Services (SIAPS), provided technical assistance to help strengthen practices regarding antibiotic prophylaxis for cesarean sections at three Ministry of Health (MOH) hospitals in Jordan—Prince Hussein Hospital, Prince Faisal Hospital, and Dr. Jameel Al Totanji Hospital.
The West and Central African regions have a low HIV prevalence. Because of the low number of patients on ART and limited technical and financial support, these regions have experienced frequent stock-outs of ARVs posing a serious risk to patients on ART and increasing the risk of HIV drug resistance in the region. As a key step in addressing this challenge, the West Africa Regional Health Office of the US Agency for International Development is providing support through the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program to address the recurring pharmaceutical supply management issues by supporting the regional coordination mechanism and the development and implementation of an early warning system (EWS) for antiretrovirals (ARVs) and HIV and AIDS related commodities.
As part of project startup, SIAPS conducted a situational analysis in Burkina Faso, Cameroon, Guinea, Niger, and Togo to gain an understanding of the current capacity for HIV and AIDS commodities management and supply. Also analyzed was the readiness of the HIV and AIDS commodities information management systems to provide the information necessary for routine monitoring of HIV and AIDS product availability in the region.
A Protocol for Rapid Situational Analysis of the HIV and AIDS Commodity Supply Chain in Seven Target West African Countries
As part of project startup, SIAPS will conduct a situational analysis of seven countries (Benin, Burkina Faso, Cameroon, Guinea, Mauritania, Niger, and Togo) to gain an understanding of the current capacity for HIV and AIDS commodities management and supply. The situational analysis will also assess the readiness of the HIV and AIDS commodities information management systems to provide the information necessary for routine monitoring of HIV and AIDS product availability in the region.
The findings from the situational analysis will inform the development of appropriate interventions that will bridge the gaps and serve as a basis for establishing a regional coordination mechanism for HIV/AIDS commodities management.
Alerts of stock-outs of life-saving medicines for antiretroviral therapy (ART) and treating opportunistic infections have emerged from a number of countries in West Africa. Several root causes of stock-outs have been identified such as poor coordination and information sharing among partners. The West Africa HIV and AIDS Regional Dashboard, called HIV and AIDS Commodity Tracking […]
By: Jean Bedel Evi Antiretroviral (ARV) medicines are a matter of life or death for people who are HIV-positive. In West Africa, the US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) is working to make sure people have uninterrupted access to these life-saving medicines. With support provided by the US President’s Emergency Plan […]
- Pharmaceutical management considerations for expanded coverage of essential health services and financial protection programs
The UN adoption of the SDGs in 2015 signaled a strong commitment of member countries to the expanded access to […]
SIAPS provided technical assistance to facilitate the expedited assessment and registration of new and existing ARV formulations to support the […]
- Strengthening Registration and Quality Assurance Systems for Generic ARVs, Related Medicines, and Devices in Namibia
In Namibia, USAID has been providing funding for technical assistance in the areas of pharmaceutical management and systems strengthening since […]